How has been the historical performance of Natural Biocon?

Answer:The historical performance of Natural Biocon shows a fluctuating trend in its financial metrics over the years.

Breakdown:
Natural Biocon's net sales have seen significant growth from Mar'20, where it reported no sales, to Mar'25 with sales of 8.35 Cr, although it decreased from 13.53 Cr in Mar'24. The total operating income followed a similar pattern, rising from 0.00 Cr in Mar'20 to 8.35 Cr in Mar'25, but also down from the previous year. The company’s total expenditure, excluding depreciation, increased from 0.03 Cr in Mar'20 to 8.29 Cr in Mar'25, reflecting the rising costs associated with its operations. Operating profit (PBDIT) fluctuated, peaking at 0.24 Cr in Mar'23 before dropping to 0.06 Cr in Mar'25. Profit before tax also showed a decline from 0.25 Cr in Mar'23 to 0.06 Cr in Mar'25, while profit after tax decreased from 0.18 Cr in Mar'23 to 0.04 Cr in Mar'25. The earnings per share (EPS) peaked at 0.16 in Mar'23 but fell to 0.02 in Mar'25. The company's total assets grew from 12.71 Cr in Mar'20 to 16.77 Cr in Mar'24, with total liabilities also increasing from 12.71 Cr in Mar'20 to 16.77 Cr in Mar'24. However, cash flow from operating activities remained stagnant at 0.00 Cr across the years. Overall, while Natural Biocon has shown growth in sales and assets, profitability has been inconsistent, particularly in the last two years.